Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions

Elie Rassy; Florence Le Roy; Cristina Smolenschi; Marine Valéry; Valérie Boige; Michel Ducreux; Alice Boilève

doi:10.1001/jamaoncol.2022.7136

Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions

JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136.

Authors

Elie Rassy¹, Florence Le Roy^{1

2}, Cristina Smolenschi¹, Marine Valéry¹, Valérie Boige¹, Michel Ducreux^{1

3}, Alice Boilève^{1

3}

Affiliations

¹ Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
² Service de Gastroentérologie, Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France.
³ Faculté de Médecine Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France.

No abstract available

Plain language summary

This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.

Publication types

Letter

MeSH terms

Antineoplastic Agents* / adverse effects
Colorectal Neoplasms* / drug therapy
Humans
Oxaliplatin / adverse effects

Substances

Oxaliplatin
Antineoplastic Agents